Chengliang Zhang

Chengliang Zhang started their career at Cornell University, where they held the positions of Postdoc from January 2011 to December 2015, and Research Associate from January 2016 to June 2017. In July 2017, they co-founded Alteron Therapeutics and currently holds the role of Co-Founder.

Chengliang Zhang attended Michigan State University from 2005 to 2010. During this time, they pursued a Doctor of Philosophy (PhD) degree in Genetics.